1. Motor Neuron Diseases Fact Sheet, National Institute of Neurological Disorders and Stroke, NIH,
www.ninds.nih.gov
.
http://www.ninds.nih.gov/disorders/motor_neuron_diseases/motor_neuron_diseases.htm
. Accessed on 5th Oct 2012.
2. Johnson FO, Yuan Y, Hajela RK, Chitrakar A, Parsell DM, Atchison WD. Exposure to an environmental neurotoxicant hastens the onset of amyotrophic lateral sclerosis-like phenotype in human Cu2+/Zn2+ superoxide dismutase 1 G93A mice: glutamate-mediated excitotoxicity. J Pharmacol Exp Ther. 2011;338(2):518–27. doi:
10.1124/jpet.110.174466
.
3. Miller RG, Mitchell J, Lyon M, Moore D. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Cochrane Database Syst Rev (1):CD001447. doi:
10.1002/14651858.CD001447.pub2
.
4. Samanta BK, Chandra NC, Ghosh S, Mukherjee KL. Aldose metabolism in developing human fetal brain and liver. Experientia. 1984;40(12):1420–2.
5. Grégoire C, Yury G, van den Rubia B, et al. Transformation of nonfunctional spinal circuits into functional states after the loss of brain input. Nat Neurosci. 2009;12:1333–42.